By: Adam Feuerstein | 01/10/14 - 11:56 AM EST
I would have preferred to see the analysis conducted with the more inclusive Nasdaq Biotechnology Index (NBI) because the BTK tracks fewer stocks.
We assessed BTK performance relative to the S&P 500 during the week of the J.P. Morgan Healthcare Conference over the past 13 years. We observed that 85% of the time (all but 2 years), the BTK outperformed the S&P 500. From Monday to Friday during the week of the conference, the BTK increased on average by 3.0%, vs. flat S&P 500. Thus, the BTK outperformed the S&P 500 by ~2.9% on average during the week of the conference over the past 13 years
11/24/14 - 09:39 AM EST
11/19/14 - 01:25 PM EST
11/18/14 - 10:16 AM EST
11/13/14 - 04:34 PM EST
11/10/14 - 10:40 AM EST
11/24/14 - 12:58 PM EST
11/24/14 - 10:59 AM EST
11/23/14 - 17:41 PM EST
11/22/14 - 14:07 PM EST
11/21/14 - 10:53 AM EST
David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Access the tool that DOMINATES the Russell 2000 and the S&P 500.